Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Sera Prognostics Inc Cl A (SERA)

Sera Prognostics Inc Cl A (SERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS PR Newswire - Tue Jun 30, 3:05PM CDT

SALT LAKE CITY , June 30, 2026 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH PR Newswire - Wed Jun 24, 3:05PM CDT

SALT LAKE CITY , June 24, 2026 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

SERA : 2.00 (-1.48%)
SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY PR Newswire - Tue Jun 23, 3:05PM CDT

--Aligns With Growing Focus on Early Identification and Management of Preterm Birth Risk--

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION PR Newswire - Mon Jun 1, 3:05PM CDT

SALT LAKE CITY , June 1, 2026 /PRNewswire/ --  Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative...

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026 PR Newswire - Wed Apr 22, 7:05AM CDT

SALT LAKE CITY , April 22, 2026 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative...

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS PR Newswire - Wed Mar 18, 3:05PM CDT

SALT LAKE CITY , March 18, 2026 /PRNewswire/ --  Sera Prognostics Inc. , The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026 PR Newswire - Wed Mar 4, 7:05AM CST

SALT LAKE CITY , March 4, 2026 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE PR Newswire - Tue Feb 17, 7:05AM CST

SALT LAKE CITY , Feb. 17, 2026 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

SERA : 2.00 (-1.48%)
Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications PR Newswire - Wed Jan 7, 7:30AM CST

Published in the journal PREGNANCY, the PRIME Study demonstrates significant improvements in neonatal outcomes with early risk screening and targeted interventions.

SERA : 2.00 (-1.48%)
Sera Announces Publication Acceptance for PRIME Study PR Newswire - Mon Nov 24, 2025

The PRIME study, one of the largest studies on preterm birth, has been accepted for publication by a medical journal following abstract presentation earlier this year

SERA : 2.00 (-1.48%)

Barchart Exclusives

Tesla's Latest Deliveries Report Exceeded Expectations. TSLA Stock Is Falling Anyway. Barchart - 55 minutes ago
Tesla stock sinks as profitability concerns outweigh the strong Q2 delivery report. Oppenheimer continues to recommend caution on TSLA shares. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.